Serum adiponectin concentration was previously reported to be positively associated with soluble vCAM-1 level and was associated with the ED measured by the flow-mediated dilatation in type 2 DM patients with diabetic nephropathy [29]. Here, ADIPOQ is linked to diabetic kidney disease.